Collaboration Between NJ Bio and Ajinomoto Bio-Pharma to Enhance Antibody-Drug Conjugate Development NJ Bio, Inc. and Ajinomoto Bio-Pharma Services forge a collaboration to boost the development of antibody-drug conjugates through advanced technologies.

Collaboration Between NJ Bio and Ajinomoto Bio-Pharma to Enhance Antibody-Drug Conjugate Development #USA #Princeton #antibody-drug_conjugates #NJ_Bio #AJICAP™

NJ Bio and Ajinomoto Bio-Pharma Join Forces to Advance Antibody-Drug Conjugate Development NJ Bio, Inc. and Ajinomoto Bio-Pharma Services have teamed up to enhance the capabilities of antibody-drug conjugate development, promising improved therapeutic options for patients.

NJ Bio and Ajinomoto Bio-Pharma Join Forces to Advance Antibody-Drug Conjugate Development #USA #Princeton #Ajinomoto #AJICAP #NJ_Bio